AtriCure Inc.
Stock Exchange NASDAQ Stock Market
EPS
$0.47
Market Cap
$1.21 B
Shares Outstanding
38.62 M
Public Float
36.75 M

Profile

Address
7555 Innovation Way
Mason Ohio 45069
United States
Employees -
Website http://www.atricure.com
Updated 07/08/2019
AtriCure, Inc. engages provision of treatment of atrial fibrillation and left atrial appendage. It operates through the following geographical segments: United States, Europe, Asia, and Other International. Its product, Isolator Synergy Ablation System, is a surgical device that treats the persistent longstanding persistent forms of atrial fibrillation in patients undergoing certain open concomitant procedures.

Financials

View All
Created with Highcharts 5.0.14AtriCure Inc.Net Income. Fiscal year is January-December. All values USD Thousands.11 46211 46216 21116 21127 21227 21233 33833 33826 89226 89221 13721 137201320142015201620172018010k20k30k40k
Created with Highcharts 5.0.14AtriCure Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.81 88981 889107 454107 454129 088129 088155 109155 109174 716174 716201 630201 630201320142015201620172018050k100k150k200k250k

Michael H. Carrel
President, Chief Executive Officer & Director
Scott William Drake
Chairman